专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2007066779A9 NOVEL LIPASE 审中-公开
标题翻译：新手
公开(公告)号：WO2007066779A9
公开(公告)日：2008-10-23
申请号：PCT/JP2006324598
申请日：2006-12-08
申请人： SUNTORY LTD , NAKAO MASAHIRO , KANAMORI MASAKI , FUKAMI HARUKAZU , KASAI HIROAKI , OCHIAI MISA
发明人： NAKAO MASAHIRO , KANAMORI MASAKI , FUKAMI HARUKAZU , KASAI HIROAKI , OCHIAI MISA
IPC分类号： C12N15/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/20 , C12N15/09 , C12P7/62
CPC分类号： C12N9/20 , C12P7/6409 , C12P7/6436 , C12R1/01
摘要： Disclosed are: a novel lipase which is produced by a bacterium belonging to the genus Tetrasphaera and has a molecular weight of about 32 kDa; and a gene encoding the lipase. The lipase can recognize a middle-chain fatty acid as a substrate. Specifically, disclosed are: a novel lipase which is produced by a bacterium belonging to the genus Tetrasphaera, can recognize a middle-chain or long-chain fatty acid as a substrate, and has a molecular weight of about 40 kDa; and a polynucleotide encoding the lipase. Also disclosed is NITE strain P-154 of a bacterium belonging to the genus Tetrasphaera. The lipase can be used as an immobilized enzyme and is useful in the fields such as the production of a digestant or a flavoring agent, the production of a clinical test reagent, an enzyme for detergent or an oil-and-fat, and the production of an optically active intermediate for the production of an agrichemical/pharmaceutical.
摘要翻译：公开了一种新颖的脂肪酶，其由属于四泽属细菌的细菌产生并具有约32kDa的分子量; 和编码脂肪酶的基因。脂肪酶可以识别中链脂肪酸作为底物。具体地说，公开了：由属于四味属细菌的细菌产生的新型脂肪酶，可以识别中链或长链脂肪酸作为底物，分子量约40kDa; 和编码脂肪酶的多核苷酸。还公开了属于四孢属（Tetrasphaera）属的细菌的NITE菌株P-154。该脂肪酶可以作为固定化酶使用，可用于生产消化剂或调味剂，生产临床试剂，洗涤剂或油脂的酶等，的用于生产农药/药物的光学活性中间体。

2. 发明申请

WO2007004685A3 COMPOSITIONS FOR AMELIORATING A REDUCED HIGHER BRAIN FUNCTION RESULTING FROM ORGANIC BRAIN LESIONS 审中-公开
标题翻译：用于改善由有机脑损伤引起的降低的高脑功能的组合物
公开(公告)号：WO2007004685A3
公开(公告)日：2007-06-14
申请号：PCT/JP2006313437
申请日：2006-06-29
申请人： SUNTORY LTD , UNIV KANAZAWA NAT UNIV CORP , ISHIKURA YOSHIYUKI , YAMASHIMA TETSUMORI
发明人： ISHIKURA YOSHIYUKI , YAMASHIMA TETSUMORI
IPC分类号： A61P9/10 , A23L1/30 , A61K31/202 , A61K31/232 , A61K31/355 , A61K31/66 , A61K45/06 , A61P25/00 , A61P25/28
CPC分类号： A61K31/202 , A23L33/12 , A61K31/232 , A61K31/355 , A61K31/66 , A61K2300/00
摘要： A composition that has an activity of ameliorating reduced higher brain functions resulting from organic brain lesions, said composition comprising arachidonic acid and/or a compound having arachidonic acid as a constituent fatty acid as well as docosahexaenoic acid and/or a compound having docosahexaenoic acid as a constituent fatty acid.
摘要翻译：具有改善由有机脑损伤引起的较高脑功能降低的活性的组合物，所述组合物包含花生四烯酸和/或具有花生四烯酸作为构成脂肪酸的化合物以及二十二碳六烯酸和/或具有二十二碳六烯酸的化合物作为构成脂肪酸。

3. 发明申请

WO2004085582A8 LIPID-IMPROVING AGENT AND COMPOSITION CONTAINING LIPID-IMPROVING AGENT 审中-公开
标题翻译：脂肪改进剂和含脂肪改善剂的组合物
公开(公告)号：WO2004085582A8
公开(公告)日：2005-12-08
申请号：PCT/JP2004004282
申请日：2004-03-26
申请人： SUNTORY LTD , AKIMOTO KENGO , FUKAMI HARUKAZU , GODA TOSHINAO
发明人： AKIMOTO KENGO , FUKAMI HARUKAZU , GODA TOSHINAO
IPC分类号： A23D9/00 , A23L1/30 , A61K31/231 , A61K31/232 , C11C3/08 , C12P7/64
CPC分类号： C12P7/6472 , A23D9/00 , A23L33/115 , A23V2002/00 , A61K31/231 , A61K31/232 , C11C3/08 , A23V2250/5112 , A23V2250/1862
摘要： A lipid-improving agent containing a triglyceride(s) where a poly-unsaturated fatty acid is bonded to 2-position of a triglyceride(s).
摘要翻译：含有甘油三酯的脂质改进剂，其中多不饱和脂肪酸与甘油三酯的2-位结合。

4. 发明申请

WO02076918A8 NF- kappa B INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT 审中-公开
标题翻译：含有取代的苯甲酸衍生物作为有效成分的NF-κB抑制剂
公开(公告)号：WO02076918A8
公开(公告)日：2002-10-31
申请号：PCT/JP0203017
申请日：2002-03-27
申请人： SUNTORY LTD , SUNTORY BIOMEDICAL RES LTD , SUZUKI KENJI , NUNOKAWA YOUICHI , OGOU NAOHISA
发明人： SUZUKI KENJI , NUNOKAWA YOUICHI , OGOU NAOHISA
IPC分类号： C07C65/24 , C07C65/40 , C07C69/157 , C07C235/64 , C07C235/84 , C07C255/44 , C07C255/60 , C07C317/40 , C07D231/12 , C07D295/135 , C07D295/192 , A61K31/167 , A61K31/192 , A61K31/216 , A61K31/235 , A61K31/277 , A61K31/415 , A61K31/44 , A61K31/4406 , A61K31/4409 , A61K31/445 , A61K31/4453 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/506 , A61K31/5375 , A61K31/5377 , A61K31/603 , A61K31/609 , A61K31/616 , A61K31/625 , A61P29/00 , A61P31/12 , A61P37/00 , A61P43/00 , C07C69/94 , C07C255/24 , C07C255/63 , C07D211/16 , C07D213/30 , C07D213/75 , C07D215/08 , C07D233/02 , C07D239/47 , C07D295/18
CPC分类号： C07D295/192 , C07C65/24 , C07C65/40 , C07C235/64 , C07C235/84 , C07C255/44 , C07C255/60 , C07C317/40 , C07C2601/02 , C07C2601/14 , C07C2601/16 , C07D295/135
摘要： A novel NF- kappa B inhibitor represented by the following formula. (I)
摘要翻译：由下式表示的新型NF-κB抑制剂。（一世）

5. 发明申请

WO0181334A3 CYCLIC AMIDINE COMPOUNDS AND THEIR USE AS ALPHA4BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS 审中-公开
标题翻译：周期性氨基化合物及其用作ALPHA4BETA2 NICOTINIC乙酰胆碱受体配体
公开(公告)号：WO0181334A3
公开(公告)日：2002-08-08
申请号：PCT/JP0103378
申请日：2001-04-20
申请人： SUNTORY LTD , IMOTO MASAHIRO , IWANAMI TATSUYA , AKABANE MINAKO , TANI YOSHIHIRO
发明人： IMOTO MASAHIRO , IWANAMI TATSUYA , AKABANE MINAKO , TANI YOSHIHIRO
IPC分类号： A61K31/4178 , A61K31/422 , A61K31/427 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/53 , A61P1/00 , A61P9/10 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/28 , A61P43/00 , C07D233/54 , C07D239/06 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/06 , C07D405/04 , C07D405/06 , C07D409/06 , C07D413/06 , C07D417/04 , C07D417/06 , A61K31/395 , C07D237/26
CPC分类号： C07D239/06 , C07D401/04 , C07D401/06 , C07D405/04 , C07D413/06 , C07D417/04 , C07D417/06
摘要： There is provided cyclic amidine compounds of the following formula (I) wherein: A and A are hydrogen atom, optionally substituted alkyl group; optionally substituted aryl group; or optionally substituted heterocyclic group; and X is -C(R ,R )-C(R ,R )-, -C(R )=C(R )-, -C(R ,R )-C(R ,R )-C(R ,R )-, or -C(R ,R )-C(R ,R )-NH- (wherein, R , R , R , R , R , R , R , R , R , R , R R , R , R , R and R are hydrogen atom; halogen atom; optionally substituted alkyl group; optionally substituted aryl group; or optionally substituted heterocyclic group;or pharmaceutically acceptable salts thereof. These compounds have good affinity for alpha 4 beta 2 nicotinic acetylcholine receptors and activate the same to thereby exert a preventive or therapeutic effect on cerebral dysfunction.
摘要翻译：提供下式（I）的环状脒化合物，其中：A 1和A 2是氢原子，任选取代的烷基; 任选取代的芳基; 或任选取代的杂环基; 并且X是-C（R 1，R 2）-C（R 3，R 4） - ， - C（R 5）= C（R 6） C（R 7，R 8）-C（R 9，R 10）-C（R 11，R 12） - 或-C（R 13）R （R 15，R 16）-NH-（其中R 1，R 2，R 3，R 4，R 5，R 5， R 6，R 7，R 8，R 9，R 10，R 11，R 12，R 13，R 14，R 15和R 16 >是氢原子;卤素原子;任选取代的烷基;任选取代的芳基;或任选取代的杂环基;或其药学上可接受的盐。这些化合物对α4β2烟碱乙酰胆碱受体具有良好的亲和力，并激活它们从而发挥对脑功能障碍的预防或治疗作用。

6. 发明申请

WO0179170A3 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF 审中-公开
标题翻译：氨基壬酸酰胺衍生物及其含有的药物组合物
公开(公告)号：WO0179170A3
公开(公告)日：2002-06-13
申请号：PCT/JP0103198
申请日：2001-04-13
申请人： SUNTORY LTD , TAKEMOTO NAOHIRO , ANNOURA HIROKAZU , MURAYAMA NORIHITO
发明人： TAKEMOTO NAOHIRO , ANNOURA HIROKAZU , MURAYAMA NORIHITO
IPC分类号： A61K31/4468 , A61K31/454 , A61K31/5377 , A61K45/00 , A61P9/00 , A61P9/10 , A61P21/02 , A61P25/00 , A61P25/16 , A61P25/28 , A61P43/00 , C07D211/58 , C07D417/04 , G01N33/15 , G01N33/68
CPC分类号： C07D417/04 , C07D211/58
摘要： There is provided an aminophenoxyacetamide derivative of the formula (I): wherein, R to R are, independent from each other, hydrogen atom; optionally substituted alkyl group; E is -NR - and E is oxygen atom or -NR ; Q is group -X-Y-Q' (X and Y are connecting bond; X is alkylene or alkenylene group, etc.; Y is selected from the groups consisting of C=O, NHC(=O), C(=O)NH, etc.; Q' is hydrogen atom or pheny, pyridyl groups which may be substituted, etc.),or a pharmaceutically acceptable salt thereof.These compounds have neuroprotective effect by introducing the CalbindinD-28k, one of Ca -binding proteins.11
摘要翻译：提供式（I）的氨基苯氧基乙酰胺衍生物：其中R 1至R 4彼此独立地为氢原子; 任选取代的烷基; E 1是-NR 4 - ，并且E 2是氧原子或-NR 10; Q是基团-XYQ'（X和Y是连接键; X是亚烷基或亚烯基等; Y选自C = O，NHC（= O），C（= O）NH等） ; Q'是氢原子或苯基，可被取代的吡啶基等）或其药学上可接受的盐。这些化合物通过引入CalbindinD-28k，Ca 2+结合蛋白之一具有神经保护作用 0.11

7. 发明申请

WO9933840B1 PYRROLOTHIAZINE AND PYRROLOTHIAZEPINE COMPOUNDS HAVING SEROTONIN-2 RECEPTOR ANTAGONISTIC AND ALPHA1-BLOCKING ACTION 审中-公开
标题翻译：具有5-羟色胺-2受体拮抗剂和α1阻断作用的吡咯并噻嗪和吡咯并噻嗪类化合物
公开(公告)号：WO9933840B1
公开(公告)日：1999-10-14
申请号：PCT/JP9805954
申请日：1998-12-25
申请人： SUNTORY LTD , MIZUNO AKIRA , SHIBATA MAKOTO , KAMEI TOMOE , FUKAMI HARUKAZU , INOMATA NORIO
发明人： MIZUNO AKIRA , SHIBATA MAKOTO , KAMEI TOMOE , FUKAMI HARUKAZU , INOMATA NORIO
IPC分类号： A61K31/54 , A61K31/55 , A61P9/00 , A61P9/02 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P43/00 , C07D207/36 , C07D513/04
CPC分类号： C07D513/04 , C07D207/36
摘要： A pyrrolesulfonamide derivative having formula (I) wherein the ring P represented by alpha is a pyrrole ring having structure beta or psi wherein R represents alkyl, cycloalkyl, cycloalkyl-alkyl or aralkyl; the dashed line indicates the presence or absence of a bond; and, when the bond is present, Z2 is not present and Z1 represents H but, when the bond is absent, Z1 represents H and Z2 represents OH or Z1 and Z2 are combined together to represent O or a group NOR1, in which R1 represents H, or alkyl, aralkyl or aryl; stands for 0 or 1; A represents alkylene, alkenylene or alkynylene; and Y represents a group delta in which W represents CH, C= or N; m stands for 0 or 1 when W is CH or N, or m stands for 1 when W is C=; B represents a specific divalent group; E1 and E2 each independently represents H or lower alkyl; and D represents an aromatic hydrocarbon group or heterocyclic group. The compound (I) has strong serotonin-2 receptor antagonistic action and low toxicity and less side effects, and is useful as a therapeutic for circulatory diseases such as ischemic heart diseases, cerebrovascular disturbances and peripheral circulatory disturbances.
摘要翻译：具有式（I）的吡咯磺酰胺衍生物，其中由α表示的环P是具有结构β或psi的吡咯环，其中R表示烷基，环烷基，环烷基 - 烷基或芳烷基; 虚线表示存在或不存在键; 并且当键存在时，Z 2不存在且Z 1表示H，但是当该键不存在时，Z 1表示H并且Z 2表示OH或Z 1和Z 2结合在一起表示O或基团NOR 1，其中R 1表示 H或烷基，芳烷基或芳基; 代表0或1; A代表亚烷基，亚烯基或亚炔基; Y表示其中W代表CH，C =或N的基团δ; 当W是CH或N时，m代表0或1，或者当W是C =时，m代表1。 B表示特定的二价基团; E1和E2各自独立地表示H或低级烷基; D表示芳族烃基或杂环基。化合物（I）具有强烈的血清素-2受体拮抗作用，毒性低，副作用少，可用作缺血性心脏病，脑血管障碍，末梢循环障碍等循环系统疾病的治疗剂。

8. 发明申请

WO2008099796A3 A CONNECTION MECHANISM BETWEEN A BEVERAGE CONTAINER AND A BEVERAGE DISPENSER AND A BEVERAGE DISPENSER USING THE SAME 审中-公开
标题翻译：饮料容器和饮料分配器之间的连接机构和使用该饮料的饮料分配器
公开(公告)号：WO2008099796A3
公开(公告)日：2008-10-30
申请号：PCT/JP2008052220
申请日：2008-02-05
申请人： SUNTORY LTD , NAKANO TOMOHARU
发明人： NAKANO TOMOHARU
IPC分类号： B67D3/00
CPC分类号： B67D1/0807 , B67D3/0009 , B67D3/0022 , B67D3/0035 , F16L41/021
摘要： Connection mechanisms and a beverage dispenser using the same connection mechanism. Connection mechanisms between a beverage container (5) and a beverage dispenser (D) comprising: a container mount (23) having a notch (25) configured for engagement with a beverage delivering port (5d) of a beverage delivering member (5a) arranged in a beverage container; a connection member (1) having a cylindrical sharp tip portion (9) at a top end thereof to be inserted into the beverage delivering port and configured to be connected to a piping system (2a, 2b); and an operating member for inserting the connection member into the beverage delivering port, wherein an end surface of the sharp tip portion defines a guide for the beverage delivering member to move within the notch when the end surface is in contact with a perimeter edge (5e) of the beverage delivering port.
摘要翻译：连接机构和使用相同连接机构的饮料分配器。饮料容器（5）和饮料分配器（D）之间的连接机构包括：容器安装件（23），其具有构造成与饮料输送构件（5a）的饮料输送口（5d）接合的凹口（25）在饮料容器中; 连接构件（1），其顶端具有圆柱形尖端部分（9），以插入到饮料输送口中并且构造成连接到管道系统（2a，2b）; 以及用于将连接构件插入饮料输送口的操作构件，其中尖端部分的端面限定了当端表面与周边边缘（5e）接触时饮料输送构件在凹口内移动的引导件）饮料输送口。

9. 发明申请

WO2007105461A2 GENE ENCODING PROTEIN RESPONSIBLE FOR FLOCCULATION PROPERTY OF YEAST AND USE THEREOF 审中-公开
标题翻译：基因编码蛋白质的絮凝性质及其用途
公开(公告)号：WO2007105461A2
公开(公告)日：2007-09-20
申请号：PCT/JP2007053450
申请日：2007-02-19
申请人： SUNTORY LTD , NAKAO YOSHIHIRO , KODAMA YUKIKO , SHIMONAGA TOMOKO
发明人： NAKAO YOSHIHIRO , KODAMA YUKIKO , SHIMONAGA TOMOKO
IPC分类号： C07K14/435 , C12Q1/68
CPC分类号： C07K14/39
摘要： The present invention relates to a gene encoding a protein responsible for flocculation property of yeast and use thereof, in particular, a brewery yeast with appropriate flocculation property for producing desired alcoholic beverages, alcoholic beverages produced with said yeast, and a method for producing said beverages. More particularly, the present invention relates to a yeast to which suitable flocculation property for brewing desired alcoholic beverages was imparted by controlling expression level of a gene encoding a protein responsible for flocculation property of brewery yeast, especially a gene specific to a lager brewing yeast, to alcoholic beverages produced with said yeast and to a method for producing said beverages.
摘要翻译：本发明涉及编码负责酵母的絮凝性的蛋白质及其用途的基因，特别是具有适当的絮凝性的酿造酵母，用于生产所需的酒精饮料，用所述酵母生产的酒精饮料，以及所述饮料的制造方法。更具体地说，本发明涉及通过控制酿造酵母，特别是啤酒酿造酵母特异性基因的编码负责絮凝性的蛋白质的基因的表达水平来赋予酿造所需酒精饮料的合适的絮凝性的酵母，用所述酵母生产的酒精饮料和生产所述饮料的方法。

10. 发明申请

WO2007032523A3 ESTERASE GENE AND USE THEREOF 审中-公开
标题翻译：酯酶基因及其用途
公开(公告)号：WO2007032523A3
公开(公告)日：2007-06-21
申请号：PCT/JP2006318466
申请日：2006-09-12
申请人： SUNTORY LTD , NAKAO YOSHIHIRO , KODAMA YUKIKO , SHIMONAGA TOMOKO
发明人： NAKAO YOSHIHIRO , KODAMA YUKIKO , SHIMONAGA TOMOKO
IPC分类号： C07K14/435 , C12N15/09
CPC分类号： C12N9/18 , C12C12/004 , C12C12/006 , C12G1/0203 , C12P7/62
摘要： The present invention relates to a esterase gene and its uses, specifically, a brewery yeast producing alcoholic beverages with excellent aroma and flavor, alcoholic beverages produced using the yeast, a process for producing the alcoholic beverages. More particularly, the present invention relates to a yeast whose capability of producing ester, which contribute to aroma and flavor of products, was controlled by regulating expression level of IAH1 gene encoding brewery yeast esterase Iah1p, particularly nonScIAH1 gene specific to lager brewing yeast, and to a method for producing alcoholic beverages with the yeast.
摘要翻译：本发明涉及酯酶基因及其用途，具体而言，涉及生产具有优异香气和风味的酒精饮料的啤酒酵母，使用该酵母生产的酒精饮料，以及用于生产酒精饮料的方法。更具体地说，本发明涉及通过调节编码啤酒酵母酯酶Iah1p，特别是啤酒酵母特异性nonScIAH1基因的IAH1基因的表达水平来控制产生有助于产品的香气和风味的酯的能力的酵母，以及涉及用酵母生产酒精饮料的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式